8 July 2024
At the meeting of 4 June 2024 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| hepatitis E infection | 39/2024 | 40/2024 |
| mesothelioma | 41/2024 | 42/2024 |
| traumatic contusion or haematoma | 43/2024 | 44/2024 |
| cerebrovascular accident (stroke) | 45/2024 | 46/2024 |
| tuberculosis | 47/2024 | 48/2024 |
| duodenal ulcer and duodenal erosion | 49/2024 | 50/2024 |
| gastric ulcer and gastric erosion | 51/2024 | 52/2024 |
| malignant neoplasm of the bile duct | 53/2024 | 54/2024 |
| tinea | 55/2024 | 56/2024 |
| cardiomyopathy | 57/2024 | 58/2024 |
These SOPs revoke the SOPs previously determined for these conditions.
The above SOPs take effect from 23 July 2024.
Completed Investigations
The above determinations conclude the previously advertised investigations into:
New Investigations
Decided to advertise the following investigations:
- distal biceps brachii tendinopathy
- spasmodic torticollis
- Scheuermann's disease
- sarcoidosis
- Parkinson’s disease and secondary parkinsonism
- otosclerosis
- optochiasmatic arachnoiditis
- opisthorchiasis
- malignant neoplasm of the urethra
- incisional hernia
- ganglion
- cut, stab, abrasion and laceration
- clonorchiasis
- cholelithiasis
- benign neoplasm of the eye and adnexa
- Barrett's oesophagus
- antiphospholipid syndrome
- suicide and attempted suicide
The above investigation notices appear in the Government Notices Gazette of 25 June 2024.